Page last updated: 2024-09-03

ly 186126 and cyclic gmp

ly 186126 has been researched along with cyclic gmp in 2 studies

Compound Research Comparison

Studies
(ly 186126)
Trials
(ly 186126)
Recent Studies (post-2010)
(ly 186126)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
70022,3463334,062

Protein Interaction Comparison

ProteinTaxonomyly 186126 (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flawn, P; Loten, EG1
Kauffman, RF; Robertson, DW; Utterback, BG1

Other Studies

2 other study(ies) available for ly 186126 and cyclic gmp

ArticleYear
Properties and distribution of cyclic AMP phosphodiesterase from rat liver.
    The International journal of biochemistry, 1990, Volume: 22, Issue:9

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Membrane; Chromatography; Chymotrypsin; Cyclic GMP; Indoles; Insulin; Kinetics; Liver; Microsomes, Liver; Octoxynol; Polyethylene Glycols; Pyridazines; Rats; Solubility

1990
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes.
    Circulation research, 1989, Volume: 65, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding Sites; Cardiotonic Agents; Cyclic GMP; Dogs; Enzyme Activation; Hydrogen-Ion Concentration; Indoles; Ions; Membranes; Myocardium; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Sarcoplasmic Reticulum

1989